208 related articles for article (PubMed ID: 33636024)
1. Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α.
Ren H; Hu F; Wang D; Kang X; Feng X; Zhang L; Zhou B; Liu S; Yuan G
Hepatology; 2021 Aug; 74(2):723-740. PubMed ID: 33636024
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
3. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
Guo L; Guo YY; Li BY; Peng WQ; Chang XX; Gao X; Tang QQ
J Biol Chem; 2019 Aug; 294(31):11805-11816. PubMed ID: 31197036
[TBL] [Abstract][Full Text] [Related]
4. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
[TBL] [Abstract][Full Text] [Related]
5. SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway.
Leal H; Cardoso J; Valério P; Quatorze M; Carmona V; Cunha-Santos J; Pereira de Almeida L; Pereira C; Cavadas C; Gomes P
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743232
[TBL] [Abstract][Full Text] [Related]
6. NAD
Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
[No Abstract] [Full Text] [Related]
7. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
8. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
[TBL] [Abstract][Full Text] [Related]
9. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).
Xu Y; Zhu Y; Hu S; Xu Y; Stroup D; Pan X; Bawa FC; Chen S; Gopoju R; Yin L; Zhang Y
Hepatology; 2021 Jun; 73(6):2251-2265. PubMed ID: 33098092
[TBL] [Abstract][Full Text] [Related]
11. Silybin Restored CYP3A Expression through the Sirtuin 2/Nuclear Factor κ-B Pathway in Mouse Nonalcoholic Fatty Liver Disease.
Zhang R; Xu D; Zhang Y; Wang R; Yang N; Lou Y; Zhao H; Aa J; Wang G; Xie Y
Drug Metab Dispos; 2021 Sep; 49(9):770-779. PubMed ID: 34183378
[TBL] [Abstract][Full Text] [Related]
12. The role of Sirtuin 2 in sustaining functional integrity of the liver.
Park S; Chung MJ; Son JY; Yun HH; Park JM; Yim JH; Jung SJ; Lee SH; Jeong KS
Life Sci; 2021 Nov; 285():119997. PubMed ID: 34597608
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.
Luo P; Qin C; Zhu L; Fang C; Zhang Y; Zhang H; Pei F; Tian S; Zhu XY; Gong J; Mao Q; Xiao C; Su Y; Zheng H; Xu T; Lu J; Zhang J
Hepatology; 2018 Nov; 68(5):1786-1803. PubMed ID: 29698567
[TBL] [Abstract][Full Text] [Related]
14. Silybin inhibits NLRP3 inflammasome assembly through the NAD
Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
[TBL] [Abstract][Full Text] [Related]
15. SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites.
Li X; Du Y; Xue C; Kang X; Sun C; Peng H; Fang L; Han Y; Xu X; Zhao C
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240315
[TBL] [Abstract][Full Text] [Related]
16. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Gao L; Wang PX; Zhang Y; Yu CJ; Ji Y; Wang X; Zhang P; Jiang X; Jin H; Huang Z; Zhang ZR; Li H
J Hepatol; 2016 Jul; 65(1):125-136. PubMed ID: 27032381
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease.
Pan X; Zhang Y
Chin Med J (Engl); 2022 May; 135(10):1172-1181. PubMed ID: 35191422
[TBL] [Abstract][Full Text] [Related]
20. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
